These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 23565634)
1. Platelets in rheumatic diseases: friend or foe? Gasparyan AY; Ayvazyan L; Pretorius E; Kitas GD Curr Pharm Des; 2014; 20(4):552-66. PubMed ID: 23565634 [TBL] [Abstract][Full Text] [Related]
2. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Gasparyan AY; Ayvazyan L; Cocco G; Kitas GD Curr Pharm Des; 2012; 18(11):1543-55. PubMed ID: 22364138 [TBL] [Abstract][Full Text] [Related]
3. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Gasparyan AY; Ayvazyan L; Mukanova U; Yessirkepov M; Kitas GD Ann Lab Med; 2019 Jul; 39(4):345-357. PubMed ID: 30809980 [TBL] [Abstract][Full Text] [Related]
5. The Role of Autophagy in Rheumatic Disease. Feng Y; Li B; Li XY; Wu ZB Curr Drug Targets; 2018; 19(9):1009-1017. PubMed ID: 27550202 [TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction in vascular pathologies and how can it be treated. Alexandru N; Popov D; Georgescu A Thromb Res; 2012 Feb; 129(2):116-26. PubMed ID: 22035630 [TBL] [Abstract][Full Text] [Related]
7. Platelets as versatile regulators of cutaneous inflammation. Katoh N J Dermatol Sci; 2009 Feb; 53(2):89-95. PubMed ID: 18922681 [TBL] [Abstract][Full Text] [Related]
8. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases. Hu C; Lu L; Wan JP; Wen C Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011 [TBL] [Abstract][Full Text] [Related]
9. [Rheumatic diseases in pregnancy]. Märker-Hermann E; Bauer H; Gromnica-Ihle E Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134 [TBL] [Abstract][Full Text] [Related]
10. Platelet activation in essential hypertension: implications for antiplatelet treatment. Gkaliagkousi E; Passacquale G; Douma S; Zamboulis C; Ferro A Am J Hypertens; 2010 Mar; 23(3):229-36. PubMed ID: 20094035 [TBL] [Abstract][Full Text] [Related]
11. Platelets in Skin Autoimmune Diseases. Liu X; Gorzelanny C; Schneider SW Front Immunol; 2019; 10():1453. PubMed ID: 31333641 [TBL] [Abstract][Full Text] [Related]
12. Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target? Manolis AS; Tzioufas AG Curr Vasc Pharmacol; 2020; 18(5):425-430. PubMed ID: 32410564 [TBL] [Abstract][Full Text] [Related]
14. From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders. Łukasik ZM; Makowski M; Makowska JS Rheumatol Int; 2018 Jun; 38(6):959-974. PubMed ID: 29492586 [TBL] [Abstract][Full Text] [Related]
15. Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study. Ntelis K; Gkizas V; Filippopoulou A; Davlouros P; Alexopoulos D; Andonopoulos AP; Daoussis D BMC Musculoskelet Disord; 2016 May; 17():213. PubMed ID: 27188755 [TBL] [Abstract][Full Text] [Related]
17. Menopause and Rheumatic Disease. Talsania M; Scofield RH Rheum Dis Clin North Am; 2017 May; 43(2):287-302. PubMed ID: 28390570 [TBL] [Abstract][Full Text] [Related]
18. Platelets: active players in the pathogenesis of arthritis and SLE. Boilard E; Blanco P; Nigrovic PA Nat Rev Rheumatol; 2012 Sep; 8(9):534-42. PubMed ID: 22868927 [TBL] [Abstract][Full Text] [Related]
19. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes. Schrottmaier WC; Kral JB; Badrnya S; Assinger A Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241 [TBL] [Abstract][Full Text] [Related]
20. Complement in the immunopathogenesis of rheumatic disease. Sturfelt G; Truedsson L Nat Rev Rheumatol; 2012 Aug; 8(8):458-68. PubMed ID: 22664835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]